|Year : 2020 | Volume
| Issue : 7 | Page : 3639-3643
Prevalence and risk factors of depressive symptoms among dialysis patients with end-stage renal disease (ESRD) in Khartoum, Sudan: A cross-sectional study
Habab Khalid Elkheir1, Arwa Siddig Wagaella2, Safaa Badi3, Abbas Khalil4, Tarig Hassan Elzubair5, Atif Khalil6, Mohamed H Ahmed7
1 Department of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, and Faculty of Pharmacy University of Sciences and Technology (UST), Khartoum, Sudan
2 Clinical Pharmacy Program, Graduate College, Omdurman Islamic University, Khartoum, Sudan, Sudan
3 Clinical Pharmacy Department, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, Sudan, Sudan
4 Department of Medicine, Arrowe Park Hopsital, Liverpool, UK
5 Department of Psychiatry, University of Sciences and Technology (UST), Khartoum, Sudan
6 Department of Nephrology, Noble Hospital, Isle of Man, UK
7 Department of Medicine and HIV Metabolic Clinic, Milton Keynes University Hospital NHS Foundation Trust, Eagelstone, Milton Keynes, Buckinghamshire, UK
|Date of Submission||11-Jan-2020|
|Date of Decision||26-Feb-2020|
|Date of Acceptance||30-Mar-2020|
|Date of Web Publication||30-Jul-2020|
Dr. Mohamed H Ahmed
Department of Medicine and HIV Metabolic Clinic, Milton Keynes University Hospital NHS Foundation Trust, Buckinghamshire
Source of Support: None, Conflict of Interest: None
Background: Depression is the most common prevalent psychiatric condition among patients with chronic kidney disease (CKD), and especially during dialysis. This study aimed to evaluate depression symptoms in Sudanese patients with end-stage renal diseases (ESRD) who undergo hemodialysis. Methods: This is a case finding, hospital-based study recruited 75 patients on dialysis in Khartoum, Sudan. Data were analyzed by statistical package for social science (SPSS, version 23). Results: The percentage of depression symptoms that satisfies the criteria for the diagnosis of major depression disorders in patients with ESRD undergoes dialysis was 68%. The new patients who undergo dialysis for less than 1 year had more depression symptoms (66.7%) than those on dialysis for 2–3 years (21.6%) or more than 3 years with a percentage of11.8%. Chi-square test showed significant associations between depression and age, the duration of dialysis, signs of significant weight loss when no dieting, and when the clinical symptoms related to distress or social or functional impairment (P = 0.016, 0.000, 0.004, and 0.000, respectively). Logistic regression test showed that age and duration of dialysis were significantly associated with depression with (odds ratios [OR]: 0.724, 0.211) Conclusion: More than two-thirds of patients on dialysis have depressive symptoms. Risk factors associated with depression in Sudanese patients on dialysis were age, duration of dialysis, weight loss, and social and functional impairment. Future research is needed in order to assess the benefit of antidepressants in patients on dialysis. Family physicians should be aware of the association between depression and dialysis, in order to provide early treatment and prevent suicide.
Keywords: Depressive symptoms, dialysis patients, end-stage renal disease (ESRD), Khartoum, Sudan
|How to cite this article:|
Elkheir HK, Wagaella AS, Badi S, Khalil A, Elzubair TH, Khalil A, Ahmed MH. Prevalence and risk factors of depressive symptoms among dialysis patients with end-stage renal disease (ESRD) in Khartoum, Sudan: A cross-sectional study. J Family Med Prim Care 2020;9:3639-43
|How to cite this URL:|
Elkheir HK, Wagaella AS, Badi S, Khalil A, Elzubair TH, Khalil A, Ahmed MH. Prevalence and risk factors of depressive symptoms among dialysis patients with end-stage renal disease (ESRD) in Khartoum, Sudan: A cross-sectional study. J Family Med Prim Care [serial online] 2020 [cited 2020 Aug 13];9:3639-43. Available from: http://www.jfmpc.com/text.asp?2020/9/7/3639/290751
| Introduction|| |
Chronic kidney disease (CKD) can be associated with a depressive symptom that may necessitate the need for intervention and support from a psychologist/psychiatrist especially during dialysis. Worldwide, it is estimated that 5–10 million die every year from kidney disease. Importantly, depression is a common health problem across the globe and lifetime risk of 7% and females have twice the chance of having depression more than males., The World Health Organization (WHO) estimated that 4.4% of the world population has depression and incidence on the rise. For instance, the WHO estimated that incidence increased by 18.4% between 2005 and 2015.
Several studies showed an association between CKD and depression. This can be attributed to many factors such as poor physical activity, loss of family income, and leading role in the family, in addition to the dietary restriction. This may negatively influence the quality of life of the individuals. It worth mentioning that dialysis may influence cognitive function. Several studies associated depression with CKD and more prevalence was noted during dialysis., In particular, the incidence of mental disorders with CKD can range from 19% to 60% exceeding mental disorders with heart failure and diabetes. It was estimated that around 12–52% of patients on hemodialysis experience anxiety, depression, and a decrease in quality of life during dialysis, and some cases may lead to an increase in mortality. Therefore, it's not surprising that depression was a significant predictor of mortality in the dialysis population. This can be attributed to the fact dialysis restrict physical activity, certain foods, ability to work, interaction with family, and the ability to work.,,
Another important point in ESRD and dialysis and depression is the fact that significant decline in cognitive function was independent of age, sex, race, and functional-status trajectory before the initiation of dialysis. In one study in Saudi Arabia 24.2% of patients suffered with symptoms of major depression, however no one of the patients had been given anti-depressant medication, as patients received counseling. Several studies have shown evidence of benefits of starting anti-depressant treatment.,,,, Therefore, this study was designed to assess depressive symptoms in Sudanese cohort of ESRD on dialysis in an effort to deliver quality treatment of their mental health in the future.
| Methodology|| |
This study was a descriptive cross-sectional, hospital-based study. The study was conducted in Sudan in the Association for Renal Transplantation Center, which is one of the biggest centers for nephrology in Khartoum State, from February to March 2016.
Sample size and sampling method
The study samples were 75 patients with ESRD undergoing dialysis attending the center during the study period and agreed to participate in the study.
Inclusion and exclusion Criteria
All patients with ESRD attended the center for dialysis within the time of study and agreed to participate in the study were included. Patients with drug abuse, or a general medical condition (e.g. hypothyroidism) or any condition that may precipitate depression were excluded from the study.
Data collection method
We used Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR) Criteria for Major Depressive Episode (further information can be obtained directly from reference 1). DSM-IV classifies the severity of MDD episodes as “mild,” “moderate,” or “severe.” These severity subtypes rely on three different measures of severity: number of criteria symptoms, the severity of the symptoms, and degree of functional disability.
Data were analyzed by statistical package for social science (SPSS), version 23, Chicago, USA. P value was set as significant ≤0.05 at confidence interval 95%. We used descriptive statistics (frequency tables) as well as inferential statistics (Chi-square test).
Approval for the study was obtained from Sudan Association for Renal Transplant. Ethical clearance was obtained from Omdurman Islamic University, faculty of pharmacy (20-01-2016).
| Results|| |
Demographic and disease characteristics of the study participants
The sample size in this study was 75 patients, about one-third of them aged more than 50 years, 16% aged 26–30 years and only 2.7% aged 16–20 years. 60% were males. more than half of the participants (53.3%) had hypertension, only 2.7% had diabetes while 26% have no other comorbidities. the majority of them (89%) were scheduled for three dialysis sessions per week while only 9% were scheduled for two sessions [Table 1]. The duration of the dialysis was less than 1 year in 48% of the participants and more than 3 years in 22.7% of them. About 45.3% of the participants were taking Iron injection replacement, heparin, erythropoietin, folic acid, alfacalcidol, calcium, and Vitaferrol. Most of them were taking from 6 to 7 medications per day for the ESRD.
|Table 1: Demographic and disease characteristics of the study participants (n=75)|
Click here to view
The prevalence of depressive symptoms among the studies participants
According to the DSM-IV-TR criteria for major depressive episodes, we found that 68% of the participants were depressed while 32% were not. Furthermore, only five (9%) of 75 participants reported that they had a previous psychiatric illness and we found that, all of them have depressive symptoms. About two-thirds of the participants suffered from weight loss when no dieting, while 43% reported that there are signs of psychomotor agitation observed by others, about 85% of them suffered from depressed mood, 86.3% suffered from loss of interest and insomnia. While more than three-quarter participants suffered from diminished ability to think or concentrate. Interestingly, nearly two-thirds of the participants stated that the symptoms cause clinically significant distress or impairment in social occupational or other functioning areas [Table 2]. Regarding the numbers of depressive symptoms among the participants, 19.6% had 5 depressive symptoms, 29.4% had 6. While 23.5% had 7 depressive symptoms while only 11.8% had 8 symptoms and 15.7% has 9 symptoms.
|Table 2: The prevalence of depressive symptoms among the studied participants (n=75)|
Click here to view
Chi square and logistic regression test
Chi-square test showed that there were significant associations between depression and age, the duration of dialysis, signs of significant weight loss when no dieting, and when the symptoms cause clinically significant distress or impairment in social occupational or other functioning areas (P = 0.016, 0.000, 0.004, and 0.000, respectively). Logistic regression test showed that age and duration of dialysis were significantly associated with depression with (OR: 0.724, 0.211 respectively) that means younger patients were more depressed than the older ones, and when the duration of dialysis was less than 1 year were more depressed than those with the dialysis duration of more than 3 years. Males were more depressed than females by 1.4 times [Table 3].
|Table 3: Predictors for depression among dialysis patients by using logistic regression test (n=75)|
Click here to view
| Discussion|| |
68% of study populations (51 patients) satisfied the DSM-IV-TR Criteria for Major Depressive Episode., More than half of the study population considered as patients with MDD and this may be attributed to the stressful life events like undergoing continuous dialysis, having fixed fistula, diet, and water-intake restrictions. Importantly, The prevalence of depressive symptoms in patients with ESRD and dialysis in India was 44.1% and China was 29%., Other studies showed a higher prevalence of depression among hemodialysis patients. For instance, the prevalence in Saudi Arabia was 83% and in other parts of India was 83.5%.,
In this study, the duration of dialysis was significantly correlated with depression with a P value = 0.000 where patients newly undergoing dialysis were more depressed than those on longer-term dialysis. This result similar to the result of the previous study conducted in Connecticut State in the USA. The possible reasons for higher depression scores in this study can be attributed to the restriction associated with the time of dialysis, the cost of medications and the emotional burden of not able to work. However, the patients spent more than 1 year on dialysis they feel more adapted to this; so they become less depressed than those starting dialysis less than 1 year ago. Age in this study was significantly associated with depression with a P value = 0.000. The younger patients were more depressed than others and this obviously related to the concern about the nature of the course of ESRD and dialysis and complications.
Despite the fact that depression in this study was not significantly associated with co- comorbidities in dialysis patients, hypertension was found to be associated with depression as it was found in more than half of the participants. Diabetes is one of the important causes of ESRD, and was found to be associated with depression in dialysis patients. Due to the small size of individuals with diabetes in this study, diabetes was not associated with depression in patients with dialysis. It worth mentioning that none of the patients identified with depression received any treatment for depression. Despite dialysis can improve physical activity and cognitive function, it should not be viewed as a treatment of depression.,,,,, The use of antidepressants in treatment is important. In Canada, the use of antidepressants for depressed dialysis patients was associated with an improvement in depressive symptoms in more than 70% of patients to improve their QOL and help them to return to their normal life.
This study is not without limitations. The cross-sectional design may not allow for the temporal relationship for the potential risk factors and outcomes. The study may not represent all Sudan as recruitment of patients was not from all areas in Sudan and large sample size may allow for a more accurate estimation of prevalence and risk factors. Despite these limitations, the study is novel and its findings reflect the strong association between dialysis and depression and risk factors.
| Conclusion|| |
This study reflected a high incidence of depression symptoms among dialysis patients (more than two thirds the participants) with some patients having serious symptoms that necessitate urgent treatment. There were significant associations between depression and age, the duration of dialysis and signs of significant weight loss. Assessment of depression status should be performed as part of the routine practice in patients with ESRD and undergoing dialysis. Those diagnosed with depression should receive prompt treatment.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Silva Junior GB, Barbosa AM, Sliva GB, Saliva LN, Lima GR, Saliva TG, et al
. Depressive symptoms in chronic kidney disease: A comparison between patients on dialysis versus conservative treatment. Nefrollatinoam 2017;14:153-9.
Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 2018;96:414-22D.
Angst J, Dobler-Mikola A. The definition of depression. J Psychiatr Res 1984;18:401-6.
Lux V, Aggen SH, Kendler KS. The DSM-IV definition of severity of major depression: Inter-relationship and validity. Psychol Med 2010;40:1691-701.
Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003;41:105-10.
Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV. Association between depression and mortality in patients receiving long-term dialysis: A systematic review and meta-analysis. Am J Kidney Dis 2014;63:623-35.
McAdams-DeMarco MA, Tan Jw, Salter ML, Gross A, Meoni LA, Jaar BG, et al
. Frailty and cognitive function in incident hemodialysis patients. Clin J Am Soc Nephrol 2015;10:2181-9.
Dziubek W, Kowalska J, Kusztal M, Rogowski L, Golebiowski T, Nikifur M, et al
. The level of anxiety and depression in dialysis patients undertaking regular physical exercise training-A preliminary study. Kidney Blood Press Res 2016;41:86-98.
Kennedy SH, Craven JL, Rodin GM. Major depression in renal dialysis patients: An open trial of antidepressant therapy. J Clin Psychiatr 1989;50:60-3.
King-Wing Ma T, Kam-Tao Li P. Depression in dialysis patients. Nephrology (Carlton) 2016;21:639-46.
Li YN, Shapiro B, Kim JC, Zhang M1, Porszasz J, Bross R, et al.
Association between quality of life and anxiety, depression, physical activity and physical performance in maintenance hemodialysis patients. Chronic Dis Transl Med 2016;2:110-9.
Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N
Engl J Med 2009;361:1539-47.
Al Zaben F, Khalifa DA, Sehlo MG, Al Shohaib S, Shaheen F, Alhozali H, et al
. Depression in patients with chronic kidney disease on dialysis in Saudi Arabia. Int Urol Nephrol 2014;46:2393-402.
Foran E, Hannigan A, Glynn L. Prevalence of depression in patients with type 2 diabetes mellitus in Irish primary care and the impact of depression on the control of diabetes. Irish J Med Sci 2015;184:319-22.
Dipiro J, Talbert R, Yee G, Matzke G, Well B, Posey L. Pharmacotherapy Physiological Approch: Depressive Disorders. 7th
ed. Newyork: McGraw-Hill; 2008.
Stasiak CE, Bazan KS, Kuss RS, Schuinski AF, Baroni G. Prevalence of anxiety and depression and its comorbidities in patients with chronic kidney disease on hemodialysis and peritoneal dialysis. J Bras Nefrol 2014;36:325-31.
Ahlawat R, Tiwari P, D'Cruz S, Prevalence of depression and its associated factors among patients of chronic kidney disease in a public tertiary care hospital in India: A cross-sectional study. Saudi J Kidney Dis Transpl 2018;29:1165-73.
Liu X, Yang X, Yao L, Zhang Q, Sun D, Zhu X, et al
. Prevalence and related factors of depressive symptoms in hemodialysis patients in northern China and Lining Wang. BMC Psychiatry 2017;17:128.
AlDukhayel A. Prevalence of depressive symptoms among hemodialysis and peritoneal dialysis patients. Int J Health Sci (Qassim) 2015;9:9-16.
Nelson V, Rakesh PS, Simon S, Babu V, Vikraman V, Abraham S, Mohammed Y. Depression among dialysis patients attending a tertiary care hospital in Kerala, Southern India. Natl Kidney Found J Nephrol Soc Work 2015;34-37.
[Table 1], [Table 2], [Table 3]